Drug Profile
Antibacterial therapeutics - Kane Biotech
Alternative Names: Biofilm inhibitors - Kane Therapeutics; Dispersin B-based antibiofilm therapeutics - Kane Biotech; Dispersin B-based wound care therapeutics - Kane Biotech; Dispersin B/Gentamicin; DispersinB Topical wound gel; DispersinB-Gentamicin wound gel spray; Gentamicin/dispersin BLatest Information Update: 17 Oct 2022
Price :
$50
*
At a glance
- Originator University of Medicine & Dentistry of New Jersey
- Developer Kane Biotech
- Class Aminoglycosides; Anti-inflammatories; Antibacterials; Enzymes; Proteins; Small molecules
- Mechanism of Action Glycoside hydrolase stimulants; Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Wounds
- No development reported Bacterial infections